Skip to main content
. 2020 May 27;12(10):9948–9958. doi: 10.18632/aging.103260

Figure 2.

Figure 2

Kaplan-Meier survival curves of (A) overall survival and (B) biochemical recurrence (BCR)-free survival for TopBP1 expression in all patients with prostate cancer (PCa). (C) Non-metastatic survival and (D) BCR-free survival for TopBP1 expression in non-metastatic PCa patients.